In addition, TGF-β also inhibited the activity of CD4+ and CD8+ T cells, thereby facilitating the escape of cancer cells from T cell killing and the generation of a tumor microenvironment that blocks T cell action. The gene discussed is CD4; the disease is neoplasm.